Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US ...Middle East

News by : (PR Newswire) -

Read More Details
Finally We wish PressBee provided you with enough information of ( Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US )

Also on site :

Most Viewed News
جديد الاخبار